IL15 and cancer: On the other hand, IL-15 priming has been demonstrated to reduce NK cell reliance on cellular metabolism, hence, IL-15 agonists may be effective for enhancing NK cell function in metabolically challenging environments, including viral infections and cancers (67, 110).